Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials

CONTEXT: Hepatitis C virus (HCV) infection is a major cause of liver-morbidity and mortality among patients with thalassemia. Peginterferon plus ribavirin is currently the recommended therapy for hepatitis C infection in patients do not have thalassemia, but using ribavirin in patients with thalasse...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hepat Mon
Main Authors: Aminizadeh, Ehsan, Alavian, Seyed Moayyed, Akbari Sari, Ali, Ebrahimi Daryani, Nasser, Behnava, Bita
Formato: Artigo
Idioma:Inglês
Publicado: Kowsar 2016
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876663/
https://ncbi.nlm.nih.gov/pubmed/27226796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/hepatmon.28537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares